# Hematopoietic Stem Cell Support in Vasculitis

> **NCT00278512** · PHASE1 · TERMINATED · sponsor: **Northwestern University** · enrollment: 7 (actual)

## Conditions studied

- Vasculitis

## Interventions

- **BIOLOGICAL:** Autologous Stem Cell Transplant
- **BIOLOGICAL:** Allogeneic Stem Cell Transplant
- **DRUG:** Cyclophosphamide
- **DRUG:** ATG (rabbit)
- **DRUG:** G-CSF
- **DRUG:** Campath-1h
- **DRUG:** Fludarabine
- **DRUG:** Tacrolimus
- **DRUG:** Mesna

## Key facts

- **NCT ID:** NCT00278512
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-08
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** No participant enrolled over five years. No plan to continue the study.
- **Last updated:** 2018-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00278512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00278512, "Hematopoietic Stem Cell Support in Vasculitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00278512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*